Anixa Biosciences, Inc.
NASDAQ: ANIX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Amit Kumar
- Employees
- 5
- Headquarters
- San Jose, United States
- IPO year
- 1983
- Market cap
- $93.2M
- Website
- https://www.anixa.com
Loading ANIX…
Loading profile data…Frequently asked questions about ANIX
What does Anixa Biosciences, Inc. (ANIX) do?
Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within the fields of oncology (cancer) and infectious diseases. Among its therapeutic pipeline, Anixa is developing a novel chimeric endocrine receptor T...
Where does ANIX trade?
Anixa Biosciences, Inc. (ANIX) trades on the NASDAQ Capital Market.
What sector is ANIX in?
Anixa Biosciences, Inc. (ANIX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Anixa Biosciences, Inc.?
Amit Kumar is the chief executive officer of Anixa Biosciences, Inc. (ANIX).
Where is Anixa Biosciences, Inc. headquartered?
Anixa Biosciences, Inc. is headquartered in United States.
Does ANIX pay a dividend?
Anixa Biosciences, Inc. (ANIX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ANIX go public?
Anixa Biosciences, Inc. (ANIX) completed its initial public offering in 1983.